3,7,12-trihydroxycoprostanic acid has been researched along with Cerebro-Hepato-Renal Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Busson, RH; Eyssen, HJ; Janssen, GA; Mannaerts, GP; Parmentier, GG | 1 |
Casteels, M; Eyssen, HJ; Govaert, L; Mannaerts, GP; Schepers, L; Van Roermund, CW; Wanders, RJ | 1 |
Jakobs, C; Kleijer, WJ; Kok, RM; Langelaar, SA; Schutgens, RB; Stellaard, F | 1 |
3 other study(ies) available for 3,7,12-trihydroxycoprostanic acid and Cerebro-Hepato-Renal Syndrome
Article | Year |
---|---|
Synthesis and 29-14C-labeling of 3 alpha, 7 alpha, 12 alpha-trihydroxy-27-carboxymethyl-5 beta-cholestan-26-oic acid. A bile acid occurring in peroxisomal diseases.
Topics: Aldehydes; Carbon Radioisotopes; Cholic Acid; Cholic Acids; Esterification; Humans; Hydrolysis; Isotope Labeling; Magnetic Resonance Spectroscopy; Malonates; Mesylates; Microbodies; Molecular Structure; Zellweger Syndrome | 1993 |
Deficient oxidation of trihydroxycoprostanic acid in liver homogenates from patients with peroxisomal diseases.
Topics: Acetyl-CoA C-Acetyltransferase; Acetyltransferases; Cholic Acids; Humans; Lipid Peroxidation; Liver; Microbodies; Substrate Specificity; Zellweger Syndrome | 1989 |
Prenatal diagnosis of Zellweger syndrome by determination of trihydroxycoprostanic acid in amniotic fluid.
Topics: Amniocentesis; Amniotic Fluid; Cholic Acids; Female; Humans; Pregnancy; Zellweger Syndrome | 1988 |